云南白药
(000538)
| 流通市值：1011.50亿 | | | 总市值：1018.10亿 |
| 流通股本：17.73亿 | | | 总股本：17.84亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 11,061,687,096.94 | 10,887,983,161.3 | 14,022,658,758.99 | 14,719,563,531.35 |
| 应收票据及应收账款 | 12,110,894,328.02 | 10,853,013,015.76 | 10,589,354,841.5 | 10,451,529,895.49 |
| 其中：应收票据 | 1,187,237,466.32 | 929,651,911.37 | 270,141,875.67 | 346,072,424.86 |
| 应收账款 | 10,923,656,861.7 | 9,923,361,104.39 | 10,319,212,965.83 | 10,105,457,470.63 |
| 应收款项融资 | 1,975,544,825.79 | 1,887,789,780.16 | 2,370,062,256.89 | 1,723,807,715.55 |
| 预付款项 | 236,512,572.25 | 303,563,844.07 | 239,754,912.98 | 309,222,685.06 |
| 其他应收款合计 | 133,216,720.68 | 108,427,198.33 | 103,802,295.83 | 364,961,972.39 |
| 应收股利 | 6,459,810 | 10,348,033.98 | 5,410,740 | 272,906,986.36 |
| 存货 | 5,970,435,025.83 | 6,294,368,316.3 | 6,137,521,941.12 | 5,988,059,390.2 |
| 一年内到期的非流动资产 | 483,928,222.22 | 480,295,722.22 | - | - |
| 其他流动资产 | 940,452,694.53 | 788,108,579.54 | 2,402,391,385.46 | 1,830,161,506.46 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 35,436,604,060.5 | 34,150,663,141.08 | 37,400,015,187.52 | 36,434,121,741.84 |
| 非流动资产: | | | | |
| 长期股权投资 | 12,788,194,045.12 | 12,561,276,081.35 | 11,927,573,020.11 | 11,770,384,034.03 |
| 其他权益工具投资 | 71,745,000 | 71,745,000 | 71,745,000 | 71,745,000 |
| 其他非流动金融资产 | 198,598,428.58 | 387,688,897.11 | 306,879,584.47 | 312,459,342.04 |
| 投资性房地产 | 45,898,469.72 | 49,884,012.15 | 50,707,897.54 | 47,029,107.86 |
| 固定资产 | 2,979,947,182.95 | 3,012,878,828.09 | 2,557,617,098.64 | 2,601,062,934.15 |
| 在建工程 | 773,366,378.38 | 703,439,112.24 | 882,012,011.07 | 713,596,692.91 |
| 生产性生物资产 | 773,549.82 | 816,524.85 | 859,499.76 | 902,474.79 |
| 使用权资产 | 276,084,855.21 | 291,177,021.52 | 270,930,597.4 | 270,258,242.13 |
| 无形资产 | 555,414,217.53 | 561,795,787.78 | 561,565,921.17 | 570,976,982.2 |
| 开发支出 | 25,580,196.11 | 25,422,461.13 | 23,999,061.65 | 22,488,583.7 |
| 商誉 | 96,963,241.17 | 96,963,241.17 | 104,121,771.67 | 104,121,771.67 |
| 长期待摊费用 | 117,766,696.48 | 127,081,811.91 | 86,350,269.3 | 88,313,398.34 |
| 递延所得税资产 | 752,240,409.4 | 756,975,016.74 | 795,380,213.19 | 798,191,932.1 |
| 其他非流动资产 | 133,849,586.67 | 116,374,395.93 | 572,761,996.69 | 561,892,994.48 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 18,816,422,257.14 | 18,763,518,191.97 | 18,212,503,942.66 | 17,933,423,490.4 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 54,253,026,317.64 | 52,914,181,333.05 | 55,612,519,130.18 | 54,367,545,232.24 |
| 流动负债: | | | | |
| 短期借款 | 48,747,405.86 | 423,380,272.64 | 558,255,605.47 | 1,144,447,669.32 |
| 应付票据及应付账款 | 6,649,314,851.88 | 6,672,055,088.28 | 6,357,174,073.39 | 6,363,262,667.38 |
| 其中：应付票据 | 1,772,682,380.04 | 1,913,702,684.41 | 1,758,091,434.46 | 1,851,834,540.05 |
| 应付账款 | 4,876,632,471.84 | 4,758,352,403.87 | 4,599,082,638.93 | 4,511,428,127.33 |
| 预收款项 | 1,247,698.51 | 446,673.78 | 1,067,786.52 | 2,045,212.68 |
| 合同负债 | 1,732,926,055.11 | 1,916,123,387.16 | 2,490,782,805.85 | 1,762,470,306.12 |
| 应付职工薪酬 | 945,682,013.44 | 1,283,950,828.82 | 862,766,685.1 | 863,101,527.5 |
| 应交税费 | 762,252,692.31 | 466,603,767.14 | 492,965,914.56 | 515,227,950.5 |
| 其他应付款合计 | 1,361,746,563.86 | 1,386,632,676.75 | 1,327,184,983.98 | 1,380,365,853.97 |
| 应付股利 | 79,795,667.91 | 86,490,742.04 | 87,345,672.28 | 87,345,672.28 |
| 一年内到期的非流动负债 | 79,791,496 | 88,436,075.74 | 84,454,028.62 | 68,739,138.2 |
| 其他流动负债 | 658,633,717.21 | 620,862,624.93 | 1,729,236,294.27 | 1,698,311,110.99 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 12,240,342,494.18 | 12,858,491,395.24 | 13,903,888,177.76 | 13,797,971,436.66 |
| 非流动负债: | | | | |
| 长期借款 | 2,100,000 | 2,100,000 | 2,100,000 | 2,100,000 |
| 租赁负债 | 187,348,480.36 | 190,656,990.23 | 183,216,134.46 | 193,456,851.84 |
| 长期应付款 | 582,637,353.55 | 591,533,288.57 | 606,002,881.87 | 612,220,198.12 |
| 长期应付职工薪酬 | 1,388,749.03 | 1,296,365.44 | 4,021,189.58 | 4,044,355.72 |
| 预计负债 | 33,588,930.13 | 12,726,280.09 | 13,760,104.02 | 16,050,005.49 |
| 递延收益 | 299,343,423.36 | 295,493,565.32 | 279,796,210.06 | 258,295,711.44 |
| 递延所得税负债 | 109,376,166.74 | 93,867,331.53 | 74,416,327.2 | 91,307,338.06 |
| 其他非流动负债 | 1,931,554.36 | 1,931,554.36 | 1,931,554.36 | 1,931,554.36 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,217,714,657.53 | 1,189,605,375.54 | 1,165,244,401.55 | 1,179,406,015.03 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 13,458,057,151.71 | 14,048,096,770.78 | 15,069,132,579.31 | 14,977,377,451.69 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,784,262,603 | 1,784,262,603 | 1,784,262,603 | 1,784,262,603 |
| 资本公积 | 17,638,644,762.35 | 17,637,148,823.48 | 17,579,150,161.89 | 17,567,398,358.39 |
| 其他综合收益 | -101,234,886.42 | -101,263,356.31 | -94,454,128.44 | -97,906,037.73 |
| 盈余公积 | 2,530,458,968.58 | 2,530,458,968.58 | 2,530,458,968.58 | 2,530,458,968.58 |
| 未分配利润 | 18,915,978,970.36 | 16,981,339,385.76 | 18,722,962,477.74 | 17,585,064,312.79 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 40,768,110,417.87 | 38,831,946,424.51 | 40,522,380,082.77 | 39,369,278,205.03 |
| 少数股东权益 | 26,858,748.06 | 34,138,137.76 | 21,006,468.1 | 20,889,575.52 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 40,794,969,165.93 | 38,866,084,562.27 | 40,543,386,550.87 | 39,390,167,780.55 |
| 负债和股东权益合计 | 54,253,026,317.64 | 52,914,181,333.05 | 55,612,519,130.18 | 54,367,545,232.24 |
| 公告日期 | 2025-04-29 | 2025-04-01 | 2024-10-30 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |